Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Prevention of Neonatal Abstinence Syndrome
NCT01965704Phase 2Completed
- Sponsor
- Stanford University
- Start
- Sep 2014
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ondansetron in neonatal abstinence syndrome (NAS), sponsored by Stanford University. Started Sep 2014; status: completed.
02
Drugs
ondansetron
03
Conditions
neonatal abstinence syndrome (NAS)
Beyond the preview
Go deeper on NCT01965704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01965704.